Bora News

  1. Bora Pharmaceuticals And Corealis Pharma Forge Strategic Alliance To Deliver Seamless, End-To-End Oral Solid Dose Development 12/9/2025

    Bora Pharmaceuticals Co., Ltd. (“Bora”, TWSE: 6472), a global leader in pharmaceutical manufacturing, and Corealis Pharma Inc., a leading early-phase Contract Development Manufacturing Organization (CDMO), have entered into a strategic alliance to provide end-to-end services for oral solid dose (OSD) development and manufacturing. The collaboration will simplify the drug development process and provide a more scalable pathway to commercialization via a single continuum.

  2. Bora Pharmaceuticals Marks Five Years In Mississauga, Canada, Strengthening Its Commitment To Onshore And Global CDMO Excellence 12/5/2025

    Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), a global leader in pharmaceutical manufacturing, today celebrates the five-year anniversary of its Mississauga, Ontario, Canada facility, a key hub in the company’s North American operations and a cornerstone of its expanding international CDMO network. The milestone will be celebrated onsite with employees, partners, and community stakeholders.

  3. Bora Pharmaceuticals Wins Biotech Company Of The Year Award 11/6/2025

    Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), a global leader in pharmaceutical manufacturing, was named this year’s winner of the Biotech Breakthrough Awards’ Overall Biotech Company of the Year award. The honor recognized Bora’s recent growth and its unique ability to provide the hands-on reliability of a dedicated partner with the infrastructure and scale of a global leader.

  4. Bora Pharmaceuticals Leverages State-Of-The-Art Isolator Production Line To Scale Supply Of Vital Oncology Therapy 10/23/2025

    Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, will leverage its Groninger FlexPro 50 Isolator Line for Vials & Pre-filled Syringes to continue to broaden patients’ access to lifesaving treatments and therapies.

  5. Bora Pharmaceuticals Wins Canada's Safest New Employer Award 10/1/2025

    Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), a global leader in pharmaceutical manufacturing, was named this year’s winner of The Bruce Power Award for Canada’s Safest New Employer. The award, announced during the 2025 Canada’s Safest Employers ceremony in October, recognizes an exemplary safety record in less than 10 years of operation.

  6. Bora Pharmaceuticals Introduces High-Potency Liquid Capsule Technology In Taiwan 9/30/2025

    Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, has announced the addition of liquid-filled hard capsule (LFC) production capabilities at its Zhunan, Taiwan facility.

  7. Meet With Bora At CPHI Frankfurt 2025 9/2/2025

    Meet with the Bora team during CPHI Frankfurt, October 28-30, to discuss how our drug product manufacturing expertise and recent capability investments can help accelerate your products and pipeline to commercial success.

  8. Bora Pharmaceuticals Announces Multi-Year Expansion For Midwest Manufacturing Site, As Upsher-Smith Entity Split Is Finalized 8/5/2025

    Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”), a global leader in pharmaceutical manufacturing, has announced plans for significant investments to expand its manufacturing and packaging capabilities at its facility in Maple Grove, Minnesota.

  9. Bora Pharmaceuticals Hosted Iowa Governor Kim Reynolds At Subsidiary Upsher-Smith To Discuss U.S. Supply Chain And Regional Collaboration, And Presented At Regional Collaboration – U.S.A Session At Bio Asia 7/23/2025

    Bora Pharmaceuticals welcomed Iowa Governor Kim Reynolds to their Maple Grove, Minnesota facility for a roundtable discussion and site tour focused on advancing pharmaceutical innovation and exploring opportunities for regional collaboration.

  10. Bora Pharmaceuticals Adds New Filling Line To Canadian Manufacturing Facility 7/16/2025

    Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, has announced a recent investment to install a high-performance filling line from Norden Machinery at its Mississauga, Ontario manufacturing facility.